Interestingly, it has been shown that mutated forms of BRAF, NRAS, and KRAS can upregulate non-constitutive proteasome expression and reduce endoplasmic reticulum stress in multiple myeloma (Shirazi et al., 2020). This evidence concerns the gene KRAS and plasma cell myeloma.